USE OF CSAIDS IN RHINOVIRUS INFECTION

The present invention is directed to the novel use of a CSBP/p38 inhibitor for the treatment of symptoms of the common cold and the exacerbation of symptoms associated therewith in humans. La présente invention concerne l'utilisation de l'inhibiteur CSBP/p38 dans le traitement des symptôme...

Full description

Saved in:
Bibliographic Details
Main Authors GRIEGO, SANDRA, D, DILLON, SUSAN, B
Format Patent
LanguageEnglish
French
Published 22.03.2001
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to the novel use of a CSBP/p38 inhibitor for the treatment of symptoms of the common cold and the exacerbation of symptoms associated therewith in humans. La présente invention concerne l'utilisation de l'inhibiteur CSBP/p38 dans le traitement des symptômes du rhume banal et de l'exacerbation des symptômes e cette affection chez l'homme.
Bibliography:Application Number: WO2000US25386